Altinmakas Emre, Dogan Hakan, Taskin Orhun Cig, Ozoran Emre, Bugra Dursun, Adsay Volkan, Balik Emre, Gurses Bengi
Department of Radiology, Koç University School of Medicine, 34010, Istanbul, Turkey.
Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abdom Radiol (NY). 2022 Jun;47(6):1975-1987. doi: 10.1007/s00261-022-03495-4. Epub 2022 Mar 24.
To assess whether size, diameter, and large vein involvement of MR-detected extramural venous invasion (MR-EMVI) have an impact on neoadjuvant therapy response in rectal adenocarcinoma.
57 patients with locally advanced rectal adenocarcinoma scanned with MRI before and after neoadjuvant therapy were included. Two abdominal radiologists evaluated the images with special emphasis on EMVI, on initial staging and after neoadjuvant treatment. The sensitivity and specificity of MRI for detection of rest EMVI were determined. The association of various MR-EMVI characteristics including number, size, and main vein involvement with treatment response was investigated. In subjects with discordance of radiology and pathology, elastin stain was performed, and images and slides were re-evaluated on site with a multidisciplinary approach.
At initial evaluation, 17 patients were MR-EMVI negative (29.8%) and 40 were MR-EMVI positive (70.2%). Complete/near-complete responders had less number (mean 1.45) and smaller diameter of MR-EMVI (mean 1.8 mm), when compared with partial responders (2.54 and 3.3 mm; p < 0.005). The sensitivity of MRI for rest EMVI detection was high, specificity was moderate, and in one patient elastin stain changed the final decision. In five patients with rest MR-EMVI positivity, carcinoma histopathologically had a distinctive serpiginous perivascular spread, growing along the track of vascular bundle, although it did not appear in intravascular spaces.
This study demonstrates that not only the presence, but also size and number of EMVI that may be significant clinically and thus these parameters also ought to be incorporated to the MRI evaluation and prognostication of treatment response. From pathology perspective, tumors growing alongside major vessels may also reflect EMVI even if they are not demonstrably "intravascular."
评估磁共振成像(MR)检测到的壁外静脉侵犯(MR-EMVI)的大小、直径及大静脉受累情况是否对直肠腺癌新辅助治疗反应有影响。
纳入57例局部进展期直肠腺癌患者,这些患者在新辅助治疗前后均接受了MRI扫描。两名腹部放射科医生评估图像,特别关注EMVI、初始分期及新辅助治疗后的情况。确定MRI检测残留EMVI的敏感性和特异性。研究包括数量、大小和主要静脉受累情况在内的各种MR-EMVI特征与治疗反应的相关性。对于放射学和病理学结果不一致的患者,进行弹性蛋白染色,并采用多学科方法在现场重新评估图像和切片。
初始评估时,17例患者MR-EMVI阴性(29.8%),40例患者MR-EMVI阳性(70.2%)。与部分缓解者相比,完全/接近完全缓解者的MR-EMVI数量较少(平均1.45个)且直径较小(平均1.8毫米)(分别为2.54个和3.3毫米;p<0.005)。MRI检测残留EMVI的敏感性较高,特异性中等,有1例患者弹性蛋白染色改变了最终诊断。在5例残留MR-EMVI阳性的患者中,癌组织病理显示有独特的匐行性血管周围扩散,沿血管束走行生长,尽管未出现在血管腔内。
本研究表明,EMVI的存在、大小和数量不仅具有临床意义,因此这些参数也应纳入MRI对治疗反应的评估和预后判断中。从病理学角度来看,即使肿瘤未明确表现为“血管内”,沿大血管生长的肿瘤也可能反映EMVI。